Seeking Alpha

The FDA has approved Exelixis' (EXEL) cabozantinib thyroid cancer drug. Shares are halted....

The FDA has approved Exelixis' (EXEL) cabozantinib thyroid cancer drug. Shares are halted. (previous)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)